Guest guest Posted May 19, 2006 Report Posted May 19, 2006 At 07:21 AM 5/19/2006, you wrote: Despite the article's quotes of Downey, there is some interesting information in the article. Yeah, I like " 15% wouldn't mind being clinically depressed " ; somebody should tell the FDA. Hopes were high that Sanofi-Aventis would release an anorexic pill called Rimonabant, but people in the clinical trials developed depression at about that rate. Rimonabant acts as an inhibitor at cannabinoid receptors -- it takes all the fun out of puffing weed. Rimonabant was a high hope as a treatment for the " metabolic syndrome " -- it not only causes weight loss, but it seems to inhbit the pernicious metabolic activity of abdonimal fat cells -- blood lipids, CRP, insulin resistance and other risk factors drop more than can be accounted for by the weight loss. Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.